Differences in Cerebral Glucose Metabolism in ALS Patients with and without C9orf72 and SOD1 Mutations

Mitochondrial complex I abnormalities underlie neurodegeneration and cognitive decline in Alzheimer’s disease

(2022) Tatsuhiro Terada et al.   EUROPEAN JOURNAL OF NEUROLOGY

Amyotrophic lateral sclerosis with SOD1 mutations shows distinct brain metabolic changes

(2022) Antonio Canosa et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Synaptic density in carriers of C9orf72 mutations: a [ 11 C]UCB‐J PET study

(2021) Maura Malpetti et al.   Annals of Clinical and Translational Neurology

Combined brain and spinal FDG PET allows differentiation between ALS and ALS mimics

(2020) Donatienne Van Weehaeghe et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Moving towards multicenter therapeutic trials in ALS: feasibility of data pooling using different TSPO positron emission tomography (PET) radioligands.

(2020) Donatienne Van Weehaeghe et al.   JOURNAL OF NUCLEAR MEDICINE

Use of Multimodal Imaging and Clinical Biomarkers in Presymptomatic Carriers of C9orf72 Repeat Expansion

(2020) Joke De Vocht et al.   JAMA Neurology

Amyotrophic lateral sclerosis: a clinical review

(2020) P. Masrori et al.   EUROPEAN JOURNAL OF NEUROLOGY

Mitochondrial Dysfunction, Neurogenesis, and Epigenetics: Putative Implications for Amyotrophic Lateral Sclerosis Neurodegeneration and Treatment

(2020) Michele Longoni Calió et al.   Frontiers in Neuroscience

11 C‐PK11195 PET–based molecular study of microglia activation in SOD1 amyotrophic lateral sclerosis

(2020) Giacomo Tondo et al.   Annals of Clinical and Translational Neurology

Positron Emission Tomography Molecular Imaging Biomarkers for Amyotrophic Lateral Sclerosis

(2019) Sheena Chew et al.   Frontiers in Neurology

FDG-PET underscores the key role of the thalamus in frontotemporal lobar degeneration caused by C9ORF72 mutations

(2019) Janine Diehl-Schmid et al.   Translational Psychiatry

Glial Contribution to Excitatory and Inhibitory Synapse Loss in Neurodegeneration

(2019) Christopher M. Henstridge et al.   Frontiers in Cellular Neuroscience

Genetics of amyotrophic lateral sclerosis: A review

(2019) Stéphane Mathis et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Automated anatomical labelling atlas 3

(2019) Edmund T. Rolls et al.   NEUROIMAGE

ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?

(2019) Rita Mejzini et al.   Frontiers in Neuroscience

Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD

(2018) Alexander Starr et al.   BRAIN RESEARCH

Project MinE: study design and pilot analyses of a large-scale whole-genome sequencing study in amyotrophic lateral sclerosis

(2018)   EUROPEAN JOURNAL OF HUMAN GENETICS

Unraveling ALS due toSOD1mutation through the combination of brain and cervical cord MRI

(2018) Federica Agosta et al.   NEUROLOGY

Atrophy in the Thalamus But Not Cerebellum Is Specific for C9orf72 FTD and ALS Patients – An Atlas-Based Volumetric MRI Study

(2018) Sonja Schönecker et al.   Frontiers in Aging Neuroscience

Glucose metabolic brain patterns to discriminate amyotrophic lateral sclerosis from Parkinson plus syndromes

(2018) Martijn Devrome et al.   EJNMMI Research

Comorbidity of dementia with amyotrophic lateral sclerosis (ALS): insights from a large multicenter Italian cohort

(2017) Francesca Trojsi et al.   JOURNAL OF NEUROLOGY

Amyotrophic lateral sclerosis

(2017) Michael A van Es et al.   LANCET

Amyloid- and FDG-PET imaging in amyotrophic lateral sclerosis

(2016) Jordi A. Matías-Guiu et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Prospective Validation of 18F-FDG Brain PET Discriminant Analysis Methods in the Diagnosis of Amyotrophic Lateral Sclerosis

(2016) D. Van Weehaeghe et al.   JOURNAL OF NUCLEAR MEDICINE

Comparative analysis of C9orf72 and sporadic disease in an ALS clinic population

(2016) Mfon E. Umoh et al.   NEUROLOGY

Genotype-phenotype correlations of amyotrophic lateral sclerosis

(2016) Hong-Fu Li et al.   Translational Neurodegeneration

Clinicopathological characteristics of patients with amyotrophic lateral sclerosis resulting in a totally locked-in state (communication Stage V)

(2016) Kentaro Hayashi et al.   Acta Neuropathologica Communications

18F-FDG-PET correlates of cognitive impairment in ALS

(2015) Antonio Canosa et al.   NEUROLOGY

The Spectrum of C9orf72-mediated Neurodegeneration and Amyotrophic Lateral Sclerosis

(2015) Johnathan Cooper-Knock et al.   Neurotherapeutics

Genotype-phenotype relationship in hereditary amyotrophic lateral sclerosis

(2015) Satoshi Yamashita et al.   Translational Neurodegeneration

The widening spectrum of C9ORF72-related disease; genotype/phenotype correlations and potential modifiers of clinical phenotype

(2014) Johnathan Cooper-Knock et al.   ACTA NEUROPATHOLOGICA

The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients

(2014) Angelina Cistaro et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

The phenotypic variability of amyotrophic lateral sclerosis

(2014) Bart Swinnen et al.   Nature Reviews Neurology

Functional pattern of brain FDG-PET in amyotrophic lateral sclerosis

(2014) M. Pagani et al.   NEUROLOGY

Value of18Fluorodeoxyglucose–Positron-Emission Tomography in Amyotrophic Lateral Sclerosis

(2014) Koen Van Laere et al.   JAMA Neurology

TARDBPandFUSMutations Associated with Amyotrophic Lateral Sclerosis: Summary and Update

(2013) Serena Lattante et al.   HUMAN MUTATION

Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations

(2012) J. S. Snowden et al.   BRAIN

Cognitive decline and reduced survival inC9orf72expansion frontotemporal degeneration and amyotrophic lateral sclerosis

(2012) David J Irwin et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Microglial Activation Correlates with Disease Progression and Upper Motor Neuron Clinical Symptoms in Amyotrophic Lateral Sclerosis

(2012) Johannes Brettschneider et al.   PLoS One

Benefit of the Awaji diagnostic algorithm for amyotrophic lateral sclerosis: A prospective study

(2011) Maarten Schrooten et al.   ANNALS OF NEUROLOGY

Brain hypermetabolism in amyotrophic lateral sclerosis: a FDG PET study in ALS of spinal and bulbar onset

(2011) Angelina Cistaro et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS

(2011) Mariely DeJesus-Hernandez et al.   NEURON

A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD

(2011) Alan E. Renton et al.   NEURON

SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: genotype-phenotype correlations

(2010) S. Millecamps et al.   JOURNAL OF MEDICAL GENETICS